Substantiation for Approaches to Treatment of Latent Autoimmune Diabetes in Adults
Mìžnarodnij Endokrinologìčnij Žurnal, 2014 The objective of this study was to substantiate the approaches to the treatment of latent autoimmune diabetes in adults on the basis of a comprehensive clinical examination of patients with this form of the disease. Research design and methods. The study
T.M. Tykhonova
doaj +2 more sources
Latent autoimmune diabetes in adults: a modern look at the problem
Mìžnarodnij Endokrinologìčnij Žurnal, 2019 The lecture provides modern information on latent autoimmune diabetes in adults. Data of literature on the epidemiology, factors and mechanisms of development, clinical features of this disease are presented.
N.V. Pashkovska
doaj +2 more sources
Latent Autoimmune Diabetes in Adults and Metabolic Syndrome—A Mini Review [PDF]
Frontiers in Endocrinology, 2022 Latent autoimmune diabetes in adults (LADA) is a heterogeneous subtype of diabetes characterized by islet cell destruction mediated by islet autoimmunity and insulin resistance.
Niansi Pan, Shimei Yang, Xiaohong Niu
doaj +2 more sources
An HIV-Infected Patient Developed Immune Reconstitution Inflammatory Syndrome Immune Reconstitution Inflammatory Syndrome After Antiretroviral Therapy and Was Diagnosed with Primary Immune Thrombocytopenia, Latent Autoimmune Diabetes in Adults, and Hashimoto Thyroiditis: A Case Report and Review of the Literature [PDF]
Infection and Drug ResistanceLele Yu,1 Binhai Zhang,1 Hu Wan,1 Huimin Ying,2 Xiaolu Qian2 1Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People’s Hospital, Hangzhou, Zhejiang, 310023, People’s Republic of China; 2Department of Endocrinology, Hangzhou ...
Yu L, Zhang B, Wan H, Ying H, Qian X
doaj +2 more sources
All-Cause Mortality and Cardiovascular and Microvascular Diseases in Latent Autoimmune Diabetes in Adults. [PDF]
Diabetes Care, 2023 OBJECTIVE Latent autoimmune diabetes in adults (LADA) is a heterogenous, slowly progressing autoimmune diabetes. We aim to contribute new knowledge on the long-term prognosis of LADA with varying degrees of autoimmunity by comparing it to type 2 diabetes
Wei Y +7 more
europepmc +3 more sources
Immune and metabolic changes leading to diabetes [PDF]
, 2012 PhDEnvironmental factors are strong determinants of diabetes-predictive biomarkers. We found these environmentally-determined biomarkers included, advanced glycation end-product serum carboxymethyl lysine (CML), a glycotoxin and diabetes-associated ...
Hawa, Mohammed Iqbal
core +4 more sources
Latent Autoimmune Diabetes in Adults [PDF]
The Journal of Clinical Endocrinology & Metabolism, 2009 Autoantibodies that are reactive to islet antigens are present at the time of diagnosis in most patients with type 1 diabetes. Additionally, approximately 10% of phenotypic type 2 diabetic patients are positive for at least one of the islet autoantibodies, and this group is often referred to as "latent autoimmune diabetes in adults (LADA)." These ...
Ramachandra G, Naik +2 more
openaire +2 more sources
B Lymphocytes in Latent Autoimmune Diabetes in Adults: From Autoimmune Activation to Immunometabolic Heterogeneity and Precision Therapeutic Perspectives. [PDF]
Diabetes Metab Res RevABSTRACT Latent autoimmune diabetes in adults (LADA) is a heterogeneous form of autoimmune diabetes characterised by adult onset, the presence of islet autoantibodies, and a slower progression to insulin dependence compared with classical type 1 diabetes.
Zouali M.
europepmc +2 more sources
Journal of Diabetes Investigation, 2022 Aims/Introduction The optimal therapy for latent autoimmune diabetes in adults (LADA) remains undefined. Increasing evidence has shown that sitagliptin and insulin treatment can benefit patients with LADA, but the efficacy still lacks systematic ...
Tong Lin +5 more
doaj +1 more source
Modern understanding of latent autoimmune diabetes in adults
Сахарный диабет, 2023 Latent autoimmune diabetes in adults (LADA) according to various sources is from 4 to 12% of all cases of type 2 diabetes mellitus (T2DM). Its uniqueness lies in the simultaneous combination of autoantibodies to β-cells (characteristic of T1DM) and the ...
I. I. Golodnikov +4 more
doaj +1 more source